Utility of P2Y12 Reactive Unit Assessment on Ticagrelor in Cerebral Aneurysms Treated with Intracranial Stenting and Flow Diversion: Cohort Study and Case Report From Two Neurovascular Centers

Bohan, Christian; Wirtz, Mirja; Hendrix, Philipp; Goren, Oded; Schirmer, Clemens; Islak, Civan; Grassi, Dante; Dalal, Shamsher; Weiner, Gregory; Griessenauer, Christoph

doi:10.1016/j.wneu.2020.07.052

Utility of P2Y12 Reactive Unit Assessment on Ticagrelor in Cerebral Aneurysms Treated with Intracranial Stenting and Flow Diversion: Cohort Study and Case Report From Two Neurovascular Centers

Bohan C. O., Wirtz M. M., Hendrix P., Goren O., Schirmer C. M., Islak C., ...Daha Fazla

WORLD NEUROSURGERY, cilt.142, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 142
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.wneu.2020.07.052
Dergi Adı: WORLD NEUROSURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Index Islamicus, MEDLINE, Veterinary Science Database
İstanbul Üniversitesi Adresli: Evet

Özet

BACKGROUND: Dual antiplatelet therapy consisting of aspirin and clopidogrel is the standard of care for neuro-interventional stenting and flow diversion. Platelet function testing has been increasingly performed to identify patients with a hypo- or hyper-response to clopidogrel. Ticagrelor has been a popular alternative antiplatelet agent for such patients. We assessed the role of platelet function testing in patients receiving ticagrelor and undergoing stenting or flow diversion.